Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
The European Journal of Health Economics
Published in: The European Journal of Health Economics 7/2020

01-09-2020 | Obsessive-Compulsive Disorder | Original Paper

Quantifying the economic impact of caregiving for Duchenne muscular dystrophy (DMD) in Spain

Authors: David Flores, María P. Ribate, Marisol Montolio, Feliciano J. Ramos, Manuel Gómez, Cristina B. García

Published in: The European Journal of Health Economics | Issue 7/2020

Login to get access

Abstract

Aim

To establish the potential economic burden in caregivers to patients with DMD and the potential causative factors.

Method

Caregivers to patients with DMD were recruited through the DMD patients Register and questioned about several economic aspects using “ad-hoc” questionnaires.

Results

All families, apart from one (97.2% n = 36), incurred in monthly medical costs (44% of the families more than 50 euros/month). 97.2% of the households considered looking after a patient of DMD as financially burdensome, and 80.5% of households declared to have suffered work changes, especially the mothers (job timetable-related mainly). The presence of obsessive–compulsive disorders (OCD) in patients was significantly associated with caregivers’ high financial burden as these were six times more likely to have this perception OR = 6468 IC 95% (1056–39,601), p = 0.043. Also, when patients had learning difficulties, caregivers had up to six times more chances to incur in monthly expenditure for formal care OR = 6089 IC 95% (1112–33,342), p = 0.037.

Interpretation

Caregivers have relevant financial burden that might be conditioned by the clinical condition of the patient.

What this paper adds

  • Quantitative data about financial burden in DMD Spanish families providing informal care.
  • Identification of the patient’s main clinical issues associated with financial burden.
Literature
1.
2.
Nguyen, D.L., Chao, D.C., Ma, G., Morgan, T.R.: Quality of life of primary caregivers of patients with chronic liver disease: a pilot study. Gastroenterology 146(5), S1004–S1005 (2014)CrossRef
3.
4.
Landfeldt, E., Lindgren, P., Bell, C.F., et al.: The burden of Duchenne muscular dystrophy: an international, cross-sectional study. Neurology 83(6), 529–536 (2014)PubMedPubMedCentralCrossRef
5.
Achury, D., Castaño, H.M., Gómez, L.A., Guevara, N.M.: Quality of life of caregivers of patients with chronic diseases. Investigación. en. Enferm.: Imagen. Desarrollo. 13(1), 27–46 (2011)
6.
Landfeldt, E., Lindgren, P., Bell, C.F., et al.: Quantifying the burden of caregiving in Duchenne muscular dystrophy. J. Neurol. 263(5), 906–915 (2016)PubMedPubMedCentralCrossRef
7.
Adelman, R.D., Tmanova, L.L., Delgado, D., Dion, S., Lachs, M.S.: Caregiver Burden. A clinical review. Jama J. Am. Med. Assoc. 311(10), 1052–1059 (2014)CrossRef
8.
Schulz, R., Beach, S.R.: Caregiving as a risk factor for mortality: the caregiver health effects study. Jama J. Am. Med. Assoc. 282(23), 2215–2219 (1999)CrossRef
9.
Gouin, J.-P., Hantsoo, L., Kiecolt-Glaser, J.K.: Immune Dysregulation and chronic stress among older adults: a review. NeuroImmunoModulation 15(4–6), 251–259 (2008)PubMedPubMedCentralCrossRef
10.
Lee, S., Colditz, G.A., Berkman, L.F., Kawachi, I.: Caregiving and risk of coronary heart disease in US women: a prospective study. Am. J. Prev. Med. 24(2), 113–119 (2003)PubMedCrossRef
11.
Mah, J.K., Korngut, L., Fiest, K.M., et al.: A systematic review and meta-analysis on the epidemiology of the muscular dystrophies. Can. J. Neurol. Sci. 43(1), 163–177 (2016)PubMedCrossRef
12.
Magliano, L., D'Angelo, M.G., Vita, G., et al.: Psychological and practical difficulties among parents and healthy siblings of children with Duchenne vs. Becker muscular dystrophy: an Italian comparative study. Acta. Myol. 33(3), 136–143 (2014)PubMedPubMedCentral
13.
14.
15.
Cavazza, M., Kodra, Y., Armeni, P., et al.: Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe. Eur. J. Health. Econ. 17(Suppl 1), 19–29 (2016)PubMedCrossRef
16.
17.
Hinton, V.J., Nereo, N.E., Fee, R.J., Cyrulnik, S.E.: Social behavior problems in boys with Duchenne muscular dystrophy. J. Dev. Behav. Pediatr. 27(6), 470–476 (2006)PubMedPubMedCentralCrossRef
18.
Magliano, L., Patalano, M., Sagliocchi, A., et al.: Burden, professional support, and social network in families of children and young adults with muscular dystrophies. Muscle. Nerve. 52(1), 13–21 (2015)PubMedPubMedCentralCrossRef
19.
20.
Kenneson, A., Bobo, J.K.: The effect of caregiving on women in families with Duchenne/Becker muscular dystrophy. Health Soc. Care Community 18(5), 520–528 (2010)PubMedCrossRef
21.
Pangalila, R.F., van den Bos, G.A., Stam, H.J., van Exel, N.J., Brouwer, W.B., Roebroeck, M.E.: Subjective caregiver burden of parents of adults with Duchenne muscular dystrophy. Disabil. Rehabil. 34(12), 988–996 (2012)PubMedCrossRef
22.
23.
24.
25.
26.
López-Bastida, J., Oliva-Moreno, J., Linertová, R., Serrano-Aguilar, P.: Social/economic costs and health-related quality of life in patients with rare diseases in Europe. Eur. J. Health Econ. 17(Suppl 1), 1–5 (2016)PubMedCrossRef
27.
Posada, M.M.C., Ramírez, A., Villaverde, A., Abitua, I.: Enfermedades Raras. Conceptos, epidemiología y situación actual en España. An. Sist. Sanit. Navar. 31, 9–20 (2008)CrossRef
28.
Alonso, J., Prieto, L., Antó, J.: La versión española del SF-36 Health Survey (Cuestionario de Salud SF-36): un instrumento para la medida de los resultados clínicos. Med. Clin. (Barc) 104(20), 771–776 (1995)
29.
Raspa, M., Sacco, P., Candrilli, S.D., Bishop, E., Petrillo, J.: Validity of a condition specific outcome measure for fragile X syndrome: the Aberrant Behaviour Checklist-utility index. J. Intellect. Disabil. Res. 60(9), 844–855 (2016)PubMedCrossRef
30.
Horsman, J., Furlong, W., Feeny, D., Torrance, G.: The Health Utilities Index (HUI®): concepts, measurement properties and applications. Health Qual. life Outcomes 1(1), 1 (2003)CrossRef
31.
Torrance, G.W.: Utility approach to measuring health-related quality of life. J. Chronic. Dis. 40(6), 593–603 (1987)PubMedCrossRef
32.
Chevreul, K., Berg Brigham, K., Brunn, M., des Portes, V., Network B-RR: Fragile X syndrome: economic burden and health-related quality of life of patients and caregivers in France. J. Intellect. Disabil. Res. 59(12), 1108–1120 (2015)PubMedCrossRef
33.
Bladen, C.L., Rafferty, K., Straub, V., et al.: The TREAT-NMD Duchenne muscular dystrophy registries: conception, design, and utilization by industry and academia. Hum. Mutat. 34(11), 1449–1457 (2013)PubMedCrossRef
34.
Kuo, D.Z., Cohen, E., Agrawal, R., Berry, J.G., Casey, P.H.: A national profile of caregiver challenges among more medically complex children with special health care needs. Arch. Pediatr. Adolesc. Med. 165(11), 1020–1026 (2011)PubMedPubMedCentralCrossRef
Metadata
Title
Quantifying the economic impact of caregiving for Duchenne muscular dystrophy (DMD) in Spain
Authors
David Flores
María P. Ribate
Marisol Montolio
Feliciano J. Ramos
Manuel Gómez
Cristina B. García
Publication date
01-09-2020
Publisher
Springer Berlin Heidelberg
Published in
The European Journal of Health Economics / Issue 7/2020
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-020-01197-6

Other articles of this Issue 7/2020

The European Journal of Health Economics 7/2020 Go to the issue

Original Paper

Cost-effectiveness of biennial screening for diabetes related retinopathy in people with type 1 and type 2 diabetes compared to annual screening

Original Paper

Cost-utility analysis of inotuzumab ozogamicin for relapsed or refractory B cell acute lymphoblastic leukemia from the perspective of Taiwan’s health care system

Original Paper

Patterns of care and cost profiles of women with breast cancer in Italy: EPICOST study based on real world data

Original Paper

Measuring intangible cost-of-morbidity due to substance dependence: implications of using alternative preference-based instruments

Editorial

Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19

Original Paper

Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN)